TNDM logo

TANDEM DIABETES CARE INC

TNDMNASDAQ
🏆 #2401 by market capEarnings Nov 5US Equity
$16.57▲ $0.15 (+0.91%)
🌙 After hours$16.60▲ 0.18%Regular close · extended-hours price shown
🔔
Track TNDM
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 0.9%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$1.14B
Small Cap
📈Revenue Growth (YoY)
+7.9%
Slowing
📊Gross Margin
56.0%
Healthy
💵FCF Margin
-2.6%
Thin
⚖️P/S Ratio
1.1x
Cheap
Otter Score
88
Very Good
TNDM logo

TANDEM DIABETES CARE INC

TNDM
Analyst Ratings
Price
$16.57
Total
39
Raised
7
Lowered
4
Avg PT
$30.17
H / L
$55 / $16
Institution
Truist Securities
Reiterated · Buy · 2026-09-24
—
—
Citigroup
Reiterated · Neutral · 2026-08-07
—
—
RBC Capital
Reiterated · Outperform · 2026-08-07
$26.00
+56.90%
Mizuho
Reiterated · Neutral · 2026-07-15
—
—
Deutsche Bank
Downgraded · Buy → Hold · 2026-06-23
$15.50
−6.50%
Wells Fargo
Upgraded · Equal Weight → Overweight · 2026-06-01
$27.00
+62.90%
B of A Securities
Reiterated · Neutral · 2026-05-18
—
—
Barclays
Reiterated · Overweight · 2026-05-11
$55.00
+231.90%
TD Cowen
Reiterated · Buy · 2026-04-20
—
—
Goldman Sachs
Reiterated · Neutral · 2026-04-09
$21.00
+26.70%
Piper Sandler
Upgraded · Neutral → Overweight · 2026-03-17
$21.00
+26.70%
Morgan Stanley
Reiterated · Equal Weight · 2026-03-02
$23.00
+38.80%
Lake Street
Upgraded · Hold → Buy · 2026-02-23
$50.00
+201.80%
Stifel
Reiterated · Hold · 2026-02-20
—
—
UBS
Reiterated · Neutral · 2026-02-20
$18.00
+8.60%
Bernstein
Reiterated · Market Perform · 2026-01-09
$25.00
+50.90%
Canaccord Genuity
Reiterated · Buy · 2025-12-17
$40.00
+141.40%
Baird
Upgraded · Neutral → Outperform · 2025-12-16
—
—
Oppenheimer
Reiterated · Outperform · 2025-09-08
$22.00
+32.80%
Leerink Partners
Upgraded · Market Perform → Outperform · 2024-04-25
$45.00
+171.60%
Jefferies
Reiterated · Buy · 2023-10-02
—
—
Craig-Hallum
Reiterated · Buy · 2023-06-13
$153.00
+823.40%
Raymond James
Downgraded · Outperform → Market Perform · 2023-04-24
$92.00
+455.20%
Cowen & Co.
Reiterated · Outperform · 2023-02-23
$141.00
+750.90%
Wolfe Research
Reiterated · Peer Perform → Perform · 2023-01-26
—
—
OTR Global
Downgraded · Positive → Mixed · 2022-09-07
—
—
SVB Leerink
Reiterated · Market Perform · 2022-05-05
—
—
Stifel Nicolaus
Reiterated · Hold · 2020-02-25
$22.00
+32.80%
Guggenheim
Reiterated · Buy · 2019-10-18
—
—
BMO Capital
Reiterated · Outperform · 2019-03-08
—
—
Berenberg
Reiterated · Buy · 2018-08-30
—
—
Dougherty
Reiterated · Buy · 2018-08-24
—
—
Bank of America
Upgraded · Underperform → Neutral · 2018-08-24
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2018-05-14
—
—
Feltl & Co.
Downgraded · Strong Buy → Buy · 2016-11-02
—
—
Wedbush
Reiterated · Outperform · 2016-11-02
—
—
B. Riley FBR
Reiterated · Buy · 2016-09-27
—
—
B. Riley
Reiterated · Buy · 2016-09-27
—
—
William Blair
Reiterated · Outperform · 2014-07-15
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space